Cargando…
Myeloid-derived suppressor cells and the efficacy of CD8(+) T-cell immunotherapy
Myeloid-derived suppressor cells (MDSCs) promote immune evasion, a key feature of oncogenesis. The restoration of immunosurveillance by immunomodulatory antibodies improves the survival of a subset of cancer patients. Preclinical studies suggest that the ablation of monocytic MDSCs may be a useful a...
Autores principales: | Lesokhin, Alexander M., Merghoub, Taha, Wolchok, Jedd D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3601158/ https://www.ncbi.nlm.nih.gov/pubmed/23525353 http://dx.doi.org/10.4161/onci.22764 |
Ejemplares similares
-
Targeting myeloid-derived suppressor cells with colony stimulating factor-1 receptor blockade can reverse immune resistance to immunotherapy in indoleamine 2,3-dioxygenase-expressing tumors
por: Holmgaard, Rikke B., et al.
Publicado: (2016) -
Myeloid-derived suppressor cells, age and cancer
por: Bowdish, Dawn ME
Publicado: (2013) -
Chemotherapeutic targeting of myeloid-derived suppressor cells
por: Alizadeh, Darya, et al.
Publicado: (2014) -
Myeloid-derived suppressor cells link inflammation to cancer
por: Wang, Dingzhi, et al.
Publicado: (2014) -
Rethinking the role of myeloid-derived suppressor cells in adoptive T-cell therapy for cancer
por: Arina, Ainhoa
Publicado: (2014)